<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03209882</url>
  </required_header>
  <id_info>
    <org_study_id>2017-0512</org_study_id>
    <nct_id>NCT03209882</nct_id>
  </id_info>
  <brief_title>Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)</brief_title>
  <official_title>Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Metabolism and Function in Post-traumatic Stress Disorder (PTSD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas at Arlington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Texas at Austin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas at Arlington</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the effects of transcranial infrared laser stimulation (TILS) on&#xD;
      prefrontal metabolism and hemodynamics in veterans with post-traumatic stress disorder&#xD;
      (PTSD). The subjects will receive six TILS interventions and one sham intervention in a&#xD;
      course of seven weeks.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-traumatic stress disorder (PTSD) is often associated with cognitive impairments. It has&#xD;
      been indicated that hypoactivity of the prefrontal cortex plays a major role in the disrupted&#xD;
      neural circuitry of mood and cognition.&#xD;
&#xD;
      Transcranial infrared laser stimulation (TILS) is a neural type of photobiomodulation that&#xD;
      can elevate neuronal metabolism by exciting cytochrome c oxidase (CCO). Veterans with PTSD&#xD;
      will receive prefrontal TILS interventions once-per-week for six weeks. They will also&#xD;
      receive an additional sham intervention (laser power = 0) that will be randomly assigned into&#xD;
      the first two sessions. Broadband near-infrared spectroscopy (bbNIRS) will be used to&#xD;
      directly assess the CCO changes during every TILS/sham session.&#xD;
&#xD;
      Veterans' prefrontal functions will be evaluated with short-term memory tasks before and&#xD;
      after each intervention. The prefrontal activities will also be imaged by functional&#xD;
      near-infrared spectroscopy (fNIRS) to objectively assess the functional changes due to&#xD;
      TILS/sham interventions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    IRB approval terminated&#xD;
  </why_stopped>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Actual">October 8, 2019</completion_date>
  <primary_completion_date type="Actual">October 8, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral CCO Changes in Response to TILS and Sham</measure>
    <time_frame>7 weeks</time_frame>
    <description>Cerebral CCO changes measured by broadband NIRS during six TILS interventions and one sham session.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebral Hemodynamic Changes in Response to TILS and Sham</measure>
    <time_frame>7 weeks</time_frame>
    <description>Cerebral hemodynamic changes measured by broadband NIRS during every TILS or sham session</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short-term Memory Scores</measure>
    <time_frame>8 weeks</time_frame>
    <description>The participant's recall time in Digit Forward (DF) task and Digit Backward (DB) task was recorded recorded during initial baseline, and after the one sham and six TILS sessions.&#xD;
The recall time indicates how fast the participants could recall that digital numbers 10 seconds after they vanished on computer screen.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prefrontal Activations in Short-term Memory Processing</measure>
    <time_frame>8 weeks</time_frame>
    <description>Anterior prefrontal hemodynamic activations (HbO2 and Hb changes) measured by functional NIRS during the Digit Forward (DF) and Digit Backward (DB) tasks. The activations were recorded from initial baseline, and after the one sham and six TILS sessions. In post-experiment processing, the activations were averaged in the recall phase, which was a key component related to PTSD.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Post-traumatic Stress Disorder (PTSD)</condition>
  <arm_group>
    <arm_group_label>One TILS, one sham, and then five TILS interventions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>One sham, then six TILS interventions</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants first received a sham session, followed by six weekly TILS sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TILS</intervention_name>
    <description>Continuous-wave laser of a specific wavelength (1064 nm) was administered to the participants' right forehead for 8 minutes. The laser power was 3.4 Watts.</description>
    <arm_group_label>One TILS, one sham, and then five TILS interventions</arm_group_label>
    <arm_group_label>One sham, then six TILS interventions</arm_group_label>
    <other_name>Low-level laser therapy (LLLT)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham</intervention_name>
    <description>The sham session consisted of administering the same laser to the participants' right forehead for totally 8 minutes. However, the laser power was turned to be 0 Watts.</description>
    <arm_group_label>One TILS, one sham, and then five TILS interventions</arm_group_label>
    <arm_group_label>One sham, then six TILS interventions</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  War-zone and non-war-zone veterans&#xD;
&#xD;
          -  Ages 18-60 years old&#xD;
&#xD;
          -  Males and females&#xD;
&#xD;
          -  Able to read, speak, and understand English&#xD;
&#xD;
          -  Medical records showing prior diagnosis of PTSD (here it refers to the records prior&#xD;
             to TILS, which will be assessed and obtained in Visit 1)&#xD;
&#xD;
          -  Medical records showing diagnosis of PTSD (here it refers to the CAPS-5 record prior&#xD;
             to TILS, which will be assessed and obtained in Visit 1)&#xD;
&#xD;
          -  On stable doses of any psychotropic medications for at least 4 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant physical disability to perform a computerized memory task&#xD;
&#xD;
          -  Past/current significant medical/neurological/mental health disorders known to affect&#xD;
             cognitive functioning (e.g., stroke, dementia, schizophrenia, AIDS)&#xD;
&#xD;
          -  Presence of moderate/severe TBI, defined as having: alteration of consciousness/mental&#xD;
             state &gt;24 hours; posttraumatic amnesia &gt;1 day; loss of consciousness &gt;30 minutes;&#xD;
             and/or abnormal structural neuroimaging. We will not exclude veterans with mild TBI,&#xD;
             which is found in nearly 50% of veterans with PTSD&#xD;
&#xD;
          -  Alcohol abuse/dependence for the past 12- months, as determined by the Rapid Alcohol&#xD;
             Problems Screen score &gt;0&#xD;
&#xD;
          -  Drug abuse/dependence for the past 12- months, as determined by the Drug Abuse&#xD;
             Screening Test-10 score &gt;2&#xD;
&#xD;
          -  Severe depression (PHQ-9 total score &gt;19), significant risk of suicide (SBQ-R &gt;6),&#xD;
             severe headache (PHQ-15, Item e =2), and/or severe dizziness (PHQ-15, Item g =2)&#xD;
&#xD;
          -  Opiate use in the month prior to study entry&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fenghua Tian, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas at Arlington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Engineering Research Building (ERB), University of Texas Arlington</name>
      <address>
        <city>Arlington</city>
        <state>Texas</state>
        <zip>76010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 30, 2017</study_first_submitted>
  <study_first_submitted_qc>July 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2017</study_first_posted>
  <results_first_submitted>March 29, 2021</results_first_submitted>
  <results_first_submitted_qc>May 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 14, 2021</results_first_posted>
  <disposition_first_submitted>January 29, 2021</disposition_first_submitted>
  <disposition_first_submitted_qc>May 18, 2021</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">June 14, 2021</disposition_first_posted>
  <last_update_submitted>June 30, 2021</last_update_submitted>
  <last_update_submitted_qc>June 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas at Arlington</investigator_affiliation>
    <investigator_full_name>Fenghua Tian, PhD</investigator_full_name>
    <investigator_title>Assistant Professor of Research</investigator_title>
  </responsible_party>
  <keyword>Transcranial infrared laser stimulation (TILS)</keyword>
  <keyword>Near-infrared spectroscopy (NIRS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Phenotypic data collected from the subjects and secondary analysis of data (if any) will be deposited at the National Database for Clinical Trials related to Mental Illness (NDCT; http://ndct.nimh.nih.gov/). It will include data collected from the subjects' forehead with optical neuroimaging modalities as well as the subjects' performance scores in three short-term memory tasks. Additional data documentation and de-identified data will be deposited for sharing along with phenotypic data, which includes demographics and PTSD scores.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Six months after completion of the project</ipd_time_frame>
    <ipd_access_criteria>Investigators working under an institution with a Federal Wide Assurance (FWA) and could be used for secondary study purposes in PTSD diagnosis and therapy.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 15, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/82/NCT03209882/Prot_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 15, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/82/NCT03209882/SAP_003.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>31 veterans were screened for eligibility between October, 2017 and November, 2018. Ten veterans met the inclusion criteria, among them nine completed the study, and one quit after the initial screening for family reason.</recruitment_details>
      <pre_assignment_details>All of the nine participants were randomly assigned into the two arms.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>One TILS, One Sham, and Then Five TILS Interventions</title>
          <description>Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.</description>
        </group>
        <group group_id="P2">
          <title>One Sham, Then Six TILS Interventions</title>
          <description>Participants first received a sham session, followed by six weekly TILS sessions.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>One TILS, One Sham, and Then Five TILS Interventions</title>
          <description>Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.</description>
        </group>
        <group group_id="B2">
          <title>One Sham, Then Six TILS Interventions</title>
          <description>Participants first received a sham session, followed by six weekly TILS sessions.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="9"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.3" spread="12.7"/>
                    <measurement group_id="B2" value="36.33" spread="12.7"/>
                    <measurement group_id="B3" value="36.3" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cerebral CCO Changes in Response to TILS and Sham</title>
        <description>Cerebral CCO changes measured by broadband NIRS during six TILS interventions and one sham session.</description>
        <time_frame>7 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>One TILS, One Sham, and Then Five TILS Interventions</title>
            <description>Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.</description>
          </group>
          <group group_id="O2">
            <title>One Sham, Then Six TILS Interventions</title>
            <description>Participants first received a sham session, followed by six weekly TILS sessions.</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral CCO Changes in Response to TILS and Sham</title>
          <description>Cerebral CCO changes measured by broadband NIRS during six TILS interventions and one sham session.</description>
          <units>microMolar/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Average CCO changes in response to sham</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.21"/>
                    <measurement group_id="O2" value="-0.33" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average CCO changes in response to 1st TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.23"/>
                    <measurement group_id="O2" value="0.70" spread="1.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average CCO changes in response to 2nd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.27"/>
                    <measurement group_id="O2" value="1.44" spread="2.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average CCO changes in response to 3rd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.26"/>
                    <measurement group_id="O2" value="2.39" spread="4.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average CCO changes in response to 4th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" spread="0.57"/>
                    <measurement group_id="O2" value="0.86" spread="1.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average CCO changes in response to 5th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.23"/>
                    <measurement group_id="O2" value="0.47" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average CCO changes in response to 6th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.13"/>
                    <measurement group_id="O2" value="1.03" spread="1.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cerebral Hemodynamic Changes in Response to TILS and Sham</title>
        <description>Cerebral hemodynamic changes measured by broadband NIRS during every TILS or sham session</description>
        <time_frame>7 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>One TILS, One Sham, and Then Five TILS Interventions</title>
            <description>Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.</description>
          </group>
          <group group_id="O2">
            <title>One Sham, Then Six TILS Interventions</title>
            <description>Participants first received a sham session, followed by six weekly TILS sessions.</description>
          </group>
        </group_list>
        <measure>
          <title>Cerebral Hemodynamic Changes in Response to TILS and Sham</title>
          <description>Cerebral hemodynamic changes measured by broadband NIRS during every TILS or sham session</description>
          <units>microMolar/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Average deoxy-Hb change in response to sham</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.40" spread="0.26"/>
                    <measurement group_id="O2" value="-0.95" spread="1.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average oxy-Hb change in response to sham</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.28" spread="1.76"/>
                    <measurement group_id="O2" value="-1.12" spread="2.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average oxy-Hb change in response to 1st TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.80" spread="1.71"/>
                    <measurement group_id="O2" value="2.77" spread="5.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average deoxy-Hb change in response to 1st TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.47"/>
                    <measurement group_id="O2" value="1.66" spread="2.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average oxy-Hb change in response to 2nd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.08" spread="1.57"/>
                    <measurement group_id="O2" value="3.58" spread="3.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average deoxy-Hb change in response to 2nd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.27"/>
                    <measurement group_id="O2" value="2.52" spread="3.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average oxy-Hb change in response to 3rd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.97" spread="1.44"/>
                    <measurement group_id="O2" value="2.60" spread="2.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average deoxy-Hb change in response to 3rd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.12" spread="0.21"/>
                    <measurement group_id="O2" value="3.37" spread="5.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average oxy-Hb change in response to 4th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.92" spread="2.19"/>
                    <measurement group_id="O2" value="2.77" spread="3.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average deoxy-Hb change in response to 4th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.21" spread="0.48"/>
                    <measurement group_id="O2" value="1.89" spread="3.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average oxy-Hb change in response to 5th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.44" spread="1.23"/>
                    <measurement group_id="O2" value="3.05" spread="1.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average deoxy-Hb change in response to 5th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.64" spread="0.54"/>
                    <measurement group_id="O2" value="1.04" spread="2.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average oxy-Hb change in response to 6th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.73" spread="1.60"/>
                    <measurement group_id="O2" value="4.93" spread="4.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average deoxy-Hb change in response to 6th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.65"/>
                    <measurement group_id="O2" value="1.31" spread="3.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Short-term Memory Scores</title>
        <description>The participant's recall time in Digit Forward (DF) task and Digit Backward (DB) task was recorded recorded during initial baseline, and after the one sham and six TILS sessions.&#xD;
The recall time indicates how fast the participants could recall that digital numbers 10 seconds after they vanished on computer screen.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>One TILS, One Sham, and Then Five TILS Interventions</title>
            <description>Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.&#xD;
TILS: Continuous-wave laser of a specific wavelength (1064 nm) was administered to the participants' right forehead for 8 minutes. The laser power was 3.4 Watts.&#xD;
sham: The sham session consisted of administering the same laser to the participants' right forehead for totally 8 minutes. However, the laser power was turned to be 0 Watts.</description>
          </group>
          <group group_id="O2">
            <title>One Sham, Then Six TILS Interventions</title>
            <description>Participants first received a sham session, followed by six weekly TILS sessions.&#xD;
TILS: Continuous-wave laser of a specific wavelength (1064 nm) was administered to the participants' right forehead for 8 minutes. The laser power was 3.4 Watts.&#xD;
sham: The sham session consisted of administering the same laser to the participants' right forehead for totally 8 minutes. However, the laser power was turned to be 0 Watts.</description>
          </group>
        </group_list>
        <measure>
          <title>Short-term Memory Scores</title>
          <description>The participant's recall time in Digit Forward (DF) task and Digit Backward (DB) task was recorded recorded during initial baseline, and after the one sham and six TILS sessions.&#xD;
The recall time indicates how fast the participants could recall that digital numbers 10 seconds after they vanished on computer screen.</description>
          <units>second</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>DF recall time, baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.1" spread="2.9"/>
                    <measurement group_id="O2" value="6.5" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB recall time, baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.8" spread="4.8"/>
                    <measurement group_id="O2" value="9.5" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF recall time, sham</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4" spread="1.3"/>
                    <measurement group_id="O2" value="5.7" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB recall time, sham</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="2.7"/>
                    <measurement group_id="O2" value="8.6" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF recall time, 1st TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1" spread="2.3"/>
                    <measurement group_id="O2" value="5.9" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB recall time, 1st TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="2.9"/>
                    <measurement group_id="O2" value="9.9" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF recall time, 2nd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="1.4"/>
                    <measurement group_id="O2" value="5.9" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB recall time, 2nd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="2.7"/>
                    <measurement group_id="O2" value="9.2" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF recall time, 3rd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" spread="1.1"/>
                    <measurement group_id="O2" value="5.9" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB recall time, 3rd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="1.7"/>
                    <measurement group_id="O2" value="11.1" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF recall time, 4th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="1.0"/>
                    <measurement group_id="O2" value="6.3" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB recall time, 4th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" spread="1.0"/>
                    <measurement group_id="O2" value="7.9" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF recall time, 5th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" spread="0.9"/>
                    <measurement group_id="O2" value="5.6" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB recall time, 5th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2" spread="1.2"/>
                    <measurement group_id="O2" value="8.5" spread="5.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF recall time, 6th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9" spread="0.6"/>
                    <measurement group_id="O2" value="5.7" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB recall time, 6th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" spread="1.5"/>
                    <measurement group_id="O2" value="7.9" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Prefrontal Activations in Short-term Memory Processing</title>
        <description>Anterior prefrontal hemodynamic activations (HbO2 and Hb changes) measured by functional NIRS during the Digit Forward (DF) and Digit Backward (DB) tasks. The activations were recorded from initial baseline, and after the one sham and six TILS sessions. In post-experiment processing, the activations were averaged in the recall phase, which was a key component related to PTSD.</description>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>One TILS, One Sham, and Then Five TILS Interventions</title>
            <description>Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.&#xD;
TILS: Continuous-wave laser of a specific wavelength (1064 nm) was administered to the participants' right forehead for 8 minutes. The laser power was 3.4 Watts.&#xD;
sham: The sham session consisted of administering the same laser to the participants' right forehead for totally 8 minutes. However, the laser power was turned to be 0 Watts.</description>
          </group>
          <group group_id="O2">
            <title>One Sham, Then Six TILS Interventions</title>
            <description>Participants first received a sham session, followed by six weekly TILS sessions.&#xD;
TILS: Continuous-wave laser of a specific wavelength (1064 nm) was administered to the participants' right forehead for 8 minutes. The laser power was 3.4 Watts.&#xD;
sham: The sham session consisted of administering the same laser to the participants' right forehead for totally 8 minutes. However, the laser power was turned to be 0 Watts.</description>
          </group>
        </group_list>
        <measure>
          <title>Prefrontal Activations in Short-term Memory Processing</title>
          <description>Anterior prefrontal hemodynamic activations (HbO2 and Hb changes) measured by functional NIRS during the Digit Forward (DF) and Digit Backward (DB) tasks. The activations were recorded from initial baseline, and after the one sham and six TILS sessions. In post-experiment processing, the activations were averaged in the recall phase, which was a key component related to PTSD.</description>
          <units>microMolar/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>DF HbO2, baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="2.2"/>
                    <measurement group_id="O2" value="0.5" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF Hb, baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="0.4"/>
                    <measurement group_id="O2" value="-0.8" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB HbO2, baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="2.2"/>
                    <measurement group_id="O2" value="-0.5" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB Hb, baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="1.0"/>
                    <measurement group_id="O2" value="0.3" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF HbO2, sham</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="3.1"/>
                    <measurement group_id="O2" value="-2.3" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF Hb, sham</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="0.7"/>
                    <measurement group_id="O2" value="-0.3" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB HbO2, sham</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="2.7"/>
                    <measurement group_id="O2" value="-0.7" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB Hb, sham</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="1.2"/>
                    <measurement group_id="O2" value="0.2" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF HbO2, 1st TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="2.0"/>
                    <measurement group_id="O2" value="-1.2" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF Hb, 1st TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" spread="0.5"/>
                    <measurement group_id="O2" value="0.1" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB HbO2, 1st TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.5" spread="4.0"/>
                    <measurement group_id="O2" value="-1.4" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB Hb, 1st TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5" spread="1.3"/>
                    <measurement group_id="O2" value="0.4" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF HbO2, 2nd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="0.8"/>
                    <measurement group_id="O2" value="0.8" spread="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF Hb, 2nd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.6"/>
                    <measurement group_id="O2" value="-1.1" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB HbO2, 2nd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="2.0"/>
                    <measurement group_id="O2" value="3.9" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB Hb, 2nd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="1.1"/>
                    <measurement group_id="O2" value="2.2" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF HbO2, 3rd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="1.7"/>
                    <measurement group_id="O2" value="0.6" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF Hb, 3rd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.2" spread="0.3"/>
                    <measurement group_id="O2" value="0.8" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB HbO2, 3rd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.3" spread="2.2"/>
                    <measurement group_id="O2" value="-1.0" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB Hb, 3rd TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.1" spread="1.1"/>
                    <measurement group_id="O2" value="0.1" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF HbO2, 4th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="2.8"/>
                    <measurement group_id="O2" value="-1.8" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF Hb, 4th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="0.7"/>
                    <measurement group_id="O2" value="0.1" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB HbO2, 4th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.3" spread="3.4"/>
                    <measurement group_id="O2" value="-1.1" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB Hb, 4th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.6"/>
                    <measurement group_id="O2" value="-0.8" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF HbO2, 5th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.2" spread="2.0"/>
                    <measurement group_id="O2" value="0.6" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF Hb, 5th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="1.0"/>
                    <measurement group_id="O2" value="0.4" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB HbO2, 5th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" spread="3.5"/>
                    <measurement group_id="O2" value="0.6" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB Hb, 5th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="1.0"/>
                    <measurement group_id="O2" value="0.4" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF HbO2, 6th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="1.2"/>
                    <measurement group_id="O2" value="-0.4" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DF Hb, 6th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.1" spread="0.9"/>
                    <measurement group_id="O2" value="0.4" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB HbO2, 6th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="2.9"/>
                    <measurement group_id="O2" value="-5.7" spread="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>DB Hb, 6th TILS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2" spread="1.4"/>
                    <measurement group_id="O2" value="0.3" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Entire course of TILS/sham sessions (7 weeks).</time_frame>
      <desc>The subjects were closely monitored in regard to physical reactions to TILS, and worsening symptoms. A 10-level VAS scale was used to measure headache and dizziness following each TILS/sham session. Severe reaction was defined as VAS ≥5. Then, the subjects were assessed for worsening PTSD symptoms (an increase of ≥24 points in Mississippi-Military), severe depression (PHQ-9 &gt; 19), risk of suicide(SBQ-R ≥ 7).</desc>
      <group_list>
        <group group_id="E1">
          <title>One TILS, One Sham, and Then Five TILS Interventions</title>
          <description>Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.</description>
        </group>
        <group group_id="E2">
          <title>One Sham, Then Six TILS Interventions</title>
          <description>Participants first received a sham session, followed by six weekly TILS sessions.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Fenghua Tian</name_or_title>
      <organization>University of Texas at Arlington</organization>
      <phone>8178075271</phone>
      <email>fenghua.tian@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

